These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28468287)

  • 1. Information Phage Therapy Research Should Report.
    Abedon ST
    Pharmaceuticals (Basel); 2017 Apr; 10(2):. PubMed ID: 28468287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage Therapy: Various Perspectives on How to Improve the Art.
    Abedon ST
    Methods Mol Biol; 2018; 1734():113-127. PubMed ID: 29288451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automating Predictive Phage Therapy Pharmacology.
    Abedon ST
    Antibiotics (Basel); 2023 Sep; 12(9):. PubMed ID: 37760719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways to Phage Therapy Enlightenment, or Why I Have Become a Scientific Curmudgeon.
    Abedon ST
    Phage (New Rochelle); 2022 Jun; 3(2):95-97. PubMed ID: 36157282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria.
    Abedon ST
    Pharmaceuticals (Basel); 2015 Sep; 8(3):559-89. PubMed ID: 26371011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further Considerations on How to Improve Phage Therapy Experimentation, Practice, and Reporting: Pharmacodynamics Perspectives.
    Abedon ST
    Phage (New Rochelle); 2022 Jun; 3(2):98-111. PubMed ID: 36148139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage therapy pharmacology: calculating phage dosing.
    Abedon S
    Adv Appl Microbiol; 2011; 77():1-40. PubMed ID: 22050820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of phage-mediated biocontrol of bacteria.
    Abedon ST
    Foodborne Pathog Dis; 2009 Sep; 6(7):807-15. PubMed ID: 19459758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active bacteriophage biocontrol and therapy on sub-millimeter scales towards removal of unwanted bacteria from foods and microbiomes.
    Abedon ST
    AIMS Microbiol; 2017; 3(3):649-688. PubMed ID: 31294181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage "delay" towards enhancing bacterial escape from biofilms: a more comprehensive way of viewing resistance to bacteriophages.
    Abedon ST
    AIMS Microbiol; 2017; 3(2):186-226. PubMed ID: 31294157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel "Superspreader" Bacteriophages Promote Horizontal Gene Transfer by Transformation.
    Keen EC; Bliskovsky VV; Malagon F; Baker JD; Prince JS; Klaus JS; Adhya SL
    mBio; 2017 Jan; 8(1):. PubMed ID: 28096488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage therapy dosing: The problem(s) with multiplicity of infection (MOI).
    Abedon ST
    Bacteriophage; 2016; 6(3):e1220348. PubMed ID: 27738558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage therapy pharmacology phage cocktails.
    Chan BK; Abedon ST
    Adv Appl Microbiol; 2012; 78():1-23. PubMed ID: 22305091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages.
    Bull JJ; Gill JJ
    Front Microbiol; 2014; 5():618. PubMed ID: 25477869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage choice, isolation, and preparation for phage therapy.
    Gill JJ; Hyman P
    Curr Pharm Biotechnol; 2010 Jan; 11(1):2-14. PubMed ID: 20214604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing phage therapeutics.
    Goodridge LD
    Curr Pharm Biotechnol; 2010 Jan; 11(1):15-27. PubMed ID: 20214605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.